| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2009 | 2013 | ||||||||
|
ATP binding cassette subfamily C member 9 | 0.552 | 0.692 | 9.4E-09 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
heat shock protein family D (Hsp60) member 1 | 0.432 | 0.808 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
glycogen phosphorylase, muscle associated | 0.650 | 0.577 | 2.0E-13 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
mitogen-activated protein kinase kinase 3 | 0.619 | 0.615 | 2.2E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
potassium two pore domain channel subfamily K member 2 | 0.626 | 0.654 | 1.9E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
lysyl oxidase | 0.447 | 0.846 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
protein kinase C delta | 0.480 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
mitofusin 1 | 0.644 | 0.577 | 2.5E-10 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
OPA1 mitochondrial dynamin like GTPase | 0.510 | 0.846 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ghrelin and obestatin prepropeptide | 0.517 | 0.769 | 1.4E-11 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
proenkephalin | 0.560 | 0.808 | 2.1E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
microtubule associated protein 1 light chain 3 beta | 0.506 | 0.846 | 1.9E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
major histocompatibility complex, class I, E | 0.545 | 0.769 | 3.7E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
phospholipase C delta 1 | 0.636 | 0.577 | 1.7E-19 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
receptor activity modifying protein 2 | 0.626 | 0.654 | 5.1E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
crystallin alpha B | 0.515 | 0.731 | 2.2E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
growth hormone secretagogue receptor | 0.528 | 0.769 | 6.6E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
eukaryotic translation initiation factor 4E | 0.448 | 0.846 | 0.94 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
eukaryotic translation initiation factor 4E binding protein 1 | 0.494 | 0.885 | 0.21 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
eukaryotic translation initiation factor 4 gamma 1 | 0.553 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 |